Insider · CIK 0001579310

Flaherty Keith T.

Reports to the SEC for 4 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001579310

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-04-03	Kinnate Biopharma Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−66.4K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.1K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−56.1K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.4K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.3K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.3K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2023-06-12	Kinnate Biopharma Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-06-13	Kinnate Biopharma Inc.Stock Option (right to buy)A Award	Director	AAward	+20.3K sh	—	—	20,250
2022-05-31	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2022-05-31	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.7K sh	—	—	0
2022-05-31	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,012 sh	—	—	0
2021-06-16	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,030
2021-06-11	Kinnate Biopharma Inc.Stock Option (right to buy)A Award	Director	AAward	+20.3K sh	—	—	20,250
2021-06-10	Clovis Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+42.2K sh	—	—	42,223
2020-06-04	Clovis Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+40.1K sh	—	—	40,138
2019-06-06	Clovis Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+28.9K sh	—	—	28,882
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,812 sh	$235.00	−$1.84M	0
2019-02-15	Loxo Oncology, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−9,732 sh	$235.00	−$2.29M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.3K sh	$235.00	−$7.6M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−68.6K sh	$235.00	−$16.1M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.5K sh	$235.00	−$7.39M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.6K sh	$235.00	−$3.67M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	$235.00	−$2.94M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,812 sh	$235.00	−$1.84M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	$235.00	−$2.59M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	$235.00	−$588K	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,750 sh	$235.00	−$2.06M	0
2018-10-11	Clovis Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+14.8K sh	—	—	14,770
2018-06-13	Loxo Oncology, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+8,750 sh	—	—	8,750
2018-06-07	Loxo Oncology, Inc.S Sale	Director	SSale	−1,900 sh	$169.85	−$323K	57,832
2018-06-07	Loxo Oncology, Inc.Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	32,345
2018-06-07	Loxo Oncology, Inc.S Sale	Director	SSale	−5,422 sh	$175.97	−$954K	9,732
2018-06-07	Loxo Oncology, Inc.S Sale	Director	SSale	−4,743 sh	$175.10	−$831K	15,154
2018-06-07	Loxo Oncology, Inc.S Sale	Director	SSale	−16K sh	$174.04	−$2.79M	19,897
2018-06-07	Loxo Oncology, Inc.S Sale	Director	SSale	−12.2K sh	$173.32	−$2.12M	35,934
2018-06-07	Loxo Oncology, Inc.S Sale	Director	SSale	−4,634 sh	$172.03	−$797K	48,177
2018-06-07	Loxo Oncology, Inc.S Sale	Director	SSale	−5,021 sh	$171.15	−$859K	52,811
2018-06-07	Loxo Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$1.18	+$59.2K	59,732
2018-01-04	Loxo Oncology, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2017-11-20	Loxo Oncology, Inc.S Sale	Director	SSale	−4,489 sh	$75.35	−$338K	12,493
2017-11-20	Loxo Oncology, Inc.S Sale	Director	SSale	−800 sh	$76.29	−$61K	11,693
2017-11-20	Loxo Oncology, Inc.S Sale	Director	SSale	−1,961 sh	$77.33	−$152K	9,732
2017-08-21	Loxo Oncology, Inc.S Sale	Director	SSale	−3,800 sh	$71.91	−$273K	20,432
2017-08-21	Loxo Oncology, Inc.S Sale	Director	SSale	−3,450 sh	$72.65	−$251K	16,982
2017-06-22	Loxo Oncology, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2017-06-08	Clovis Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-05-22	Loxo Oncology, Inc.S Sale	Director	SSale	−2,799 sh	$45.75	−$128K	24,342
2017-05-22	Loxo Oncology, Inc.S Sale	Director	SSale	−4,341 sh	$44.64	−$194K	27,141
2017-05-22	Loxo Oncology, Inc.S Sale	Director	SSale	−110 sh	$46.24	−$5,086.004	24,232

Recent filings

Accepted (ET)
Apr 54
Flaherty Keith T.0001415889-24-010428
SEC(opens sec.gov)
Jun 134
Flaherty Keith T.0001209191-23-036860
SEC(opens sec.gov)
Jun 154
Flaherty Keith T.0001209191-22-037027
SEC(opens sec.gov)
May 314
Flaherty Keith T.0000899243-22-020091
SEC(opens sec.gov)
Jun 214
Flaherty Keith T.0000899243-21-025179
SEC(opens sec.gov)
Jun 144
Flaherty Keith T.0001209191-21-040397
SEC(opens sec.gov)
Jun 114
Flaherty Keith T.0000899243-21-023421
SEC(opens sec.gov)
Jun 54
Flaherty Keith T.0000899243-20-015505
SEC(opens sec.gov)
Jun 74
Flaherty Keith T.0000899243-19-016033
SEC(opens sec.gov)
Feb 154
Flaherty Keith T.0001567619-19-004569
SEC(opens sec.gov)

Companies

Address

C/O CLOVIS ONCOLOGY, INC. 2525 28TH STREET, SUITE 100

BOULDER, CO, 80301